Latest News

The SNAP trial, which investigates the best way to treat bloodstream infections caused by Staphylococcus aureus bacteria, opened in the UK this week.
Researchers from the MRC Clinical Trials Unit at UCL have published the first study to systematically review how scientists and medical professionals characterise the different stages of tuberculosis (TB), beyond the binary of latent or active.
Our methodologists have published an article with guidance on how to check the quality of simulation studies to help prevent errors.
An oral antibiotic taken once daily for six months can substantially reduce the risk of developing multidrug-resistant (MDR) tuberculosis (TB) in both children and adults, according to two landmark clinical trials.
Qualitative data from PROUD study provides first look at the psychological and social impacts of taking oral PrEP among gay men in England.